Noninvasive prenatal testing (NIPT) is an effective method of determining the risk that the fetus will be born with certain genetic abnormalities.
NIPT helps to learn a lot about the baby during the first trimester. This is the most progressive way to diagnose chromosomal disorders and other abnormalities, utilized in all developed countries in the world.
The testing analyzes small fragments of DNA that are circulating in a pregnant woman’s blood.
The testing is recommended when:
The key advantages of NIPT include its high accuracy and safety. The possibility of diagnostic mistake is only 0.01%.
For this testing, the mother’s venous blood is used. The blood taking procedure is completely safe for both the baby, and the mother.
One more advantage is that the testing can be performed very early in the pregnancy – in the 9th week.
The testing can detect the following diseases and abnormalities:
While analyzing the fetus’ DNA, it is possible to identify its sex.
Even though NIPT is a high-accuracy method of diagnosis, it is, nevertheless, a screening test. Which means that should any abnormalities be detected during the testing, they still must be confirmed by an invasive test, such as fetal karyotyping.
The testing is not performed:
If you would like to get more information about this method of diagnosis, please, contact the clinic by phone or via the online inquiry form.